Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ozempic

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.

MarketBeat

Want to scare a Hollywood star? Just set up a fundraiser in their name

More horrifying to a celebrity than any scandal is having the public believe they’re down on their luck. Just ask Mickey Rourke, says Emma Brockes

The Guardian - UK

Tiktok Influencer Anna Paul Slams Trolls Over 'Ozempic Bruises' Claims, Denies Using Weight-Loss Drug

TikTok star Anna Paul has hit back at online trolls after claims circulated that bruises on her body were linked to Ozempic use, firmly denying she has ever taken the weight-loss drug.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Christina Aguilera Ozempic Rumours: Experts Reveal the 'Undetectable' Work Behind Her Age-Reversing 45th Look

Christina Aguilera stuns at 45 as experts reveal the subtle Ozempic, Botox, facelift, and weight-loss secrets behind her ageless look.

International Business Times UK

Goodbye angels, hello Ozempic needles – what’s behind the boom in bizarre Christmas baubles?

This year’s most-wanted ornaments include weight-loss syringes and favourite foodstuffs. When and why did Christmas trees become so commercialised?

The Guardian - UK

Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial

The stock of the Wegovy and Ozempic maker is down nearly 50% year to date.

Fortune

Gordon Ramsay is wrong – ‘Mounjaro menus’ are lifesavers for people like me

IN FOCUS: There’s a reason why millions of people in the UK are on weight-loss injections – and it’s not because we’re all weak, writes Charlotte Cripps. The food noise is real...

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported third-quarter 2025 sales of roughly $11.75 billion (74.98 billion Danish kroner), slightly below the consensus of $11.88 billion.

Benzinga

College band announcer slammed after calling plus-sized dance team ‘new face of Ozempic’

The comment was made at a football game between Florida A&M University and Alabama State University

The Independent UK

Ozempic Lawsuit: Everything You Need To Know About The Latest Vision Loss Allegations

Ozempic lawsuit: Latest vision loss allegations explained. Learn about potential stomach paralysis & gastroparesis claims. Is there a connection?

Bored Panda

Trump reportedly asks EU to levy 100% tariffs on India and China; Ozempic maker Novo to cut 9,000 jobs – as it happened

US president wants to up pressure on Russia to end war in Ukraine

The Guardian - UK

People Are Experiencing Such Bad Ozempic Side Effects That It Might Result In $2B In Lawsuits

Ozempic reportedly faces around $2 billion in lawsuits that are about its side effects.

Bored Panda

Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets

The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme.

MarketBeat

Voices: Is ‘black-market Ozempic’ ever worth the risk?

COMMENT: I’ve seen what happens to people who use counterfeit skinny jabs – as unwittingly happened to the reality star Aisleyne Horgan-Wallace – and ‘Fauxzempic’ is a gateway to a world of painful side effects, says Charlotte Lytton

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Bored Panda

“Get ‘Em Flapping”: People Crack Jokes After Experts Reveal “Ozempic Vulva” As Latest Side Effect

The phenomenon, colloquially referred to as the Ozempic vulva, is the latest side effect that’s now part of conversations around GLP-1 medications.

Bored Panda

Scientists Discover Ozempic’s Healthier Rival With No Nausea And No Side Effects

"Like starting the race halfway through.”

Fortune

Trump wants Medicare to pay for your Ozempic treatment. Taxpayers may foot the bill for billions in fraud

As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, including Wegovy, Ozempic, and Mounjaro.

The Independent UK

Cheryl Burke on years of being shamed for her weight: ‘I’m done being judged’

The former ‘Dancing With the Stars’ pro denied claims that she used Ozempic to lose weight

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Ozempic and Wegovy maker Novo Nordisk sees shares tumble on profit alert

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Bored Panda

Fans Defend Jennifer Love Hewitt Against Body Shaming After ‘I Know What You Did Last Summer’ Premiere

"At least she's not on Ozempic"

Bored Panda

“Ozempic Face”: Kelly Osbourne Reignites Rumors With New Blonde Look

"I know everybody thinks I took Ozempic. I did not take Ozempic. I don't know where that came from. My mum took Ozempic."

Bored Panda

“Stop With The Ozempic”: Kate Beckinsale’s Drastic Weight Loss And ‘Scary Thin’ Look Spark Concern

“Oh sweetheart, I honestly think you have a problem!!! You don’t look good. I think you honestly need help."

Bored Panda

‘Organ-Destroying’ Ozempic And Mounjaro Have Already Claimed 10 Lives, Experts Say

"People have been conditioned to believe you can take dr*gs for everything."

Bored Panda

Amanda Bynes Steps Out After Revealing She’s Using Ozempic And Why, Sparking Mixed Reactions

Amanda Bynes stepped out in LA after revealing she’s “excited” to start Ozempic, hoping to slim down to look better in her paparazzi pictures.

Euronews

The slimming shot: What price are you willing to pay for a dream body?

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal approval for dual purposes.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.